6-1611782-ACGGCGGCGGCGG-ACGGCGGCGG
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBS1BS2
The NM_001453.3(FOXC1):c.1359_1361delCGG(p.Gly454del) variant causes a disruptive inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00269 in 1,402,412 control chromosomes in the GnomAD database, including 4 homozygotes. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.0027 ( 1 hom., cov: 19)
Exomes 𝑓: 0.0027 ( 3 hom. )
Consequence
FOXC1
NM_001453.3 disruptive_inframe_deletion
NM_001453.3 disruptive_inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.744
Genes affected
FOXC1 (HGNC:3800): (forkhead box C1) This gene belongs to the forkhead family of transcription factors which is characterized by a distinct DNA-binding forkhead domain. The specific function of this gene has not yet been determined; however, it has been shown to play a role in the regulation of embryonic and ocular development. Mutations in this gene cause various glaucoma phenotypes including primary congenital glaucoma, autosomal dominant iridogoniodysgenesis anomaly, and Axenfeld-Rieger anomaly. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 6-1611782-ACGG-A is Benign according to our data. Variant chr6-1611782-ACGG-A is described in ClinVar as [Likely_benign]. Clinvar id is 193212.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0027 (386/143064) while in subpopulation AFR AF= 0.00891 (345/38706). AF 95% confidence interval is 0.00814. There are 1 homozygotes in gnomad4. There are 197 alleles in male gnomad4 subpopulation. Median coverage is 19. This position pass quality control queck.
BS2
High AC in GnomAd4 at 386 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FOXC1 | NM_001453.3 | c.1359_1361delCGG | p.Gly454del | disruptive_inframe_deletion | 1/1 | ENST00000645831.2 | NP_001444.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FOXC1 | ENST00000645831.2 | c.1359_1361delCGG | p.Gly454del | disruptive_inframe_deletion | 1/1 | NM_001453.3 | ENSP00000493906.1 |
Frequencies
GnomAD3 genomes AF: 0.00265 AC: 379AN: 142986Hom.: 1 Cov.: 19
GnomAD3 genomes
AF:
AC:
379
AN:
142986
Hom.:
Cov.:
19
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0159 AC: 1032AN: 64810Hom.: 0 AF XY: 0.0149 AC XY: 560AN XY: 37658
GnomAD3 exomes
AF:
AC:
1032
AN:
64810
Hom.:
AF XY:
AC XY:
560
AN XY:
37658
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00268 AC: 3380AN: 1259348Hom.: 3 AF XY: 0.00298 AC XY: 1847AN XY: 619338
GnomAD4 exome
AF:
AC:
3380
AN:
1259348
Hom.:
AF XY:
AC XY:
1847
AN XY:
619338
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00270 AC: 386AN: 143064Hom.: 1 Cov.: 19 AF XY: 0.00283 AC XY: 197AN XY: 69604
GnomAD4 genome
AF:
AC:
386
AN:
143064
Hom.:
Cov.:
19
AF XY:
AC XY:
197
AN XY:
69604
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Mar 15, 2016 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 20, 2021 | See Variant Classification Assertion Criteria. - |
Axenfeld-Rieger syndrome type 3 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at